Novel Biomarkers for Assessing Clinical Severity in Hereditary Spherocytosis - Application of Routine and Advanced Diagnostic Tests
Jonathan R.A. de Wilde(Utrecht University), Richard van Wijk(Utrecht University), Annelies J. van Vuren(University Medical Center Utrecht), Minke A.E. Rab(Utrecht University), Wouter W. van Solinge(Utrecht University), Esmé Waanders(University Medical Center Utrecht), Eduard J. van Beers(Utrecht University), Maryse E. Boesveld(University Medical Center Utrecht), Marije Bartels(University Medical Center Utrecht)
Cited by 2
Related Papers
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
|Blood|2005|366
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia
|Nature Genetics|2013|332
Deregulation of DUX4 and ERG in acute lymphoblastic leukemia
|Nature Genetics|2016|322
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162